Back to Trials
NCT07246902Recruiting

Mobilization and Outcomes After Venous Closure

Cordis US Corp.

Start Date

11/24/2025

Completion Date

8/1/2026

Summary

The primary objective of this post-market registry is to collect real-world outcomes and evaluate usage practice of MYNX CONTROL™ VENOUS (MCV) Vascular Closure Device (VCD) 6F-12F in sealing femoral venous access sites in patients who have undergone endovascular procedures in a real-world setting.

Detailed Description

The study is a single-arm, prospective, multi-center, observational, real-world registry of venous access site closures utilizing MYNX CONTROL™ VENOUS VCD 6F-12F following endovascular procedures. The study will enroll approximately 300 subjects in approximately 15 study sites in the United States.

Eligibility Criteria

Age Range: No minimum to No maximum

Inclusion Criteria 1. Able and willing to provide informed consent and to complete a follow-up visit at 14 ± 7 days post-procedure. 2. Individuals undergoing catheter-based procedures utilizing 6F to 12F inner diameter procedural sheaths, with single or multiple venous access sites in one or both limbs. 3. Individuals who are candidates to have their venous access site(s) closed with MYNX CONTROL™ VENOUS VCD 6F-12F per IFU. 4. At the time of enrollment, the Investigator deems the subject a candidate for same-day discharge (SDD) per standard of care (no procedure related events/complications e.g., no new pericardial effusion, post-procedure diuresis not needed, etc.). Exclusion Criteria 1. Presence of bruit, palpable aneurysm, significant candida or groin infection. 2. Prior to closure, presence of hematoma in the accessed limb. 3. Currently involved in any other clinical trial that may interfere with the outcomes of this study as determined by the Investigator. 4. Planned use of other closure devices or techniques other than MYNX CONTROL™ VENOUS VCD 6F-12F. 5. Life expectancy \<12 months.

Interventions

DEVICE

MYNX CONTROLTM VENOUS Vascular Closure Device

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Venous Vascular ClosureElectrophysiology Study

Locations

South Denver Cardiology

Littleton, Colorado 80210

United States

KC Heart and Rhythm Institute

Overland Park, Kansas 66211

United States

North Carolina Heart & Vascular Research, LLC

Raleigh, North Carolina 27607

United States